GS-441524 is a nucleoside analog that has been widely studied and used in veterinary applications, particularly for the treatment of Feline Infectious Peritonitis (FIP) in cats. It is the active metabolite related to antiviral research targeting feline coronavirus (FCoV), which is the underlying cause of FIP.
As an antiviral active ingredient, GS-441524 works by inhibiting viral RNA replication, helping to reduce viral load and support recovery in affected cats. Due to its mechanism of action and favorable research outcomes, GS-441524 has become one of the most recognized compounds in FIP-related studies and formulations.
| Product Name | GS-441524 |
| Expiry Date | 1 Year From The Date Of Manufacture |
| Storage Condition | Room Temperature |
| CAS | 1191237-69-0 |
| Function | Treatment For Cat FIP |
| Dosage Form | Injection |
| Country of Manufacture | China |
| Packaging | 6ml/vial, 8ml/vial, 10ml/vial |
| Strength | 20mg and 30mg |
GS-441524 is primarily applied in veterinary research and formulation development, especially in studies related to Feline Infectious Peritonitis (FIP) caused by feline coronavirus (FCoV). As a nucleoside analog with antiviral activity, it is widely used as a key active ingredient in FIP-focused research and veterinary preparations.
1. FIP-Related Veterinary Research
GS-441524 is extensively used in laboratory and clinical research exploring antiviral strategies for managing FIP in cats, including both wet and dry forms of the disease.
2. Antiviral Mechanism Studies
GS-441524 is used in research investigating viral RNA replication inhibition mechanisms against feline coronavirus, supporting antiviral drug development in veterinary medicine.
3. Veterinary Academic and Institutional Research
Universities, research institutes, and veterinary laboratories use GS-441524 for scientific studies focused on feline viral infections and related therapeutic approaches.
